This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2000 Apr;1(3):147-54.

doi: 10.1023/a:1010018829345.

The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer

Affiliations

Affiliation

¹ Division of Intramural Research, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive MSC 1771, Building 10 Room 8S235B, Bethesda, MD 20892-1771, USA. monica_skarulis@nih.gov

PMID: 11705000
DOI: 10.1023/a:1010018829345

Review

The use of recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer

M C Skarulis. Rev Endocr Metab Disord. 2000 Apr.

. 2000 Apr;1(3):147-54.

doi: 10.1023/a:1010018829345.

Author

Affiliation

¹ Division of Intramural Research, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive MSC 1771, Building 10 Room 8S235B, Bethesda, MD 20892-1771, USA. monica_skarulis@nih.gov

PMID: 11705000
DOI: 10.1023/a:1010018829345

No abstract available

PubMed Disclaimer

Similar articles

Diagnostic and therapeutic use of recombinant human TSH (rhTSH) in differentiated thyroid cancer.
Pacini F, Castagna MG. Pacini F, et al. Best Pract Res Clin Endocrinol Metab. 2008 Dec;22(6):1009-21. doi: 10.1016/j.beem.2008.09.014. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 19041828 Review.
Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective.
Zanotti-Fregonara P, Rubello D, Hindié E. Zanotti-Fregonara P, et al. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1397-9. doi: 10.1007/s00259-008-0823-0. Epub 2008 May 10. Eur J Nucl Med Mol Imaging. 2008. PMID: 18470514 No abstract available.
Clinical uses of recombinant human thyrotropin.
Gourgiotis L, Skarulis MC. Gourgiotis L, et al. Expert Opin Pharmacother. 2004 Dec;5(12):2503-14. doi: 10.1517/14656566.5.12.2503. Expert Opin Pharmacother. 2004. PMID: 15571468 Review.
Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinoma.
Dietlein M, Busemeyer S, Kobe C, Schmidt M, Theissen P, Schicha H. Dietlein M, et al. Nuklearmedizin. 2010;49(6):216-24. doi: 10.3413/nukmed-0321-1005. Epub 2010 Sep 28. Nuklearmedizin. 2010. PMID: 20877918
Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter.
Woodmansee WW, Haugen BR. Woodmansee WW, et al. Clin Endocrinol (Oxf). 2004 Aug;61(2):163-73. doi: 10.1111/j.1365-2265.2004.02025.x. Clin Endocrinol (Oxf). 2004. PMID: 15272910 Review.

See all similar articles

Cited by

Type 2 diabetes mellitus is more prevalent among patients with thyroid carcinoma and influences overall survival: a propensity score matching analysis.
Jiang T, Qiao G, Zheng X, Wen Z, Zhang D. Jiang T, et al. Oncotarget. 2017 Oct 31;8(57):97528-97536. doi: 10.18632/oncotarget.22179. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228629 Free PMC article.

References

1. Clin Endocrinol (Oxf). 1998 Nov;49(5):619-28 - PubMed
1. Ann Intern Med. 1991 Jul 15;115(2):133-47 - PubMed
1. J Clin Endocrinol Metab. 1998 Dec;83(12):4435-42 - PubMed
1. N Engl J Med. 1983 Oct 20;309(16):937-41 - PubMed
1. Thyroid. 1999 May;9(5):421-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information